NASDAQ:GRPH Graphite Bio (GRPH) Stock Price, News & Analysis → Crypto Market Preps For Trillions Worth of Inflows! (From Crypto 101 Media) (Ad) Free GRPH Stock Alerts $3.18 -0.09 (-2.75%) (As of 03/21/2024) Add Compare Share Share Today's Range$3.05▼$3.2350-Day Range$3.18▼$26.1152-Week Range$2.01▼$4.26Volume328,300 shsAverage Volume282,405 shsMarket Capitalization$185.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Graphite Bio alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About Graphite Bio Stock (NASDAQ:GRPH)Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. The company offers GPH102 for the treatment of beta-thalassemia; and GPH201 for the treatment of XSCID, a life-threatening disease for multiple mutations in a single gene. It also offers GPH301, a product candidate for the treatment of Gaucher disease, a genetic disorder that results in a deficiency in the glucocerebrosidase enzyme. The company was formerly known as Integral Medicines, Inc., and changed its name to Graphite Bio, Inc. in August 2020. Graphite Bio, Inc. was incorporated in 2017 and is based in South San Francisco, California.Read More GRPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GRPH Stock News HeadlinesMarch 21, 2024 | finance.yahoo.comLENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate ProgressMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 5.000 putMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 15, 2024 | seekingalpha.comVERI, STI and VERB among mid-day moversMarch 15, 2024 | finance.yahoo.comGRPH Mar 2024 7.500 callMarch 14, 2024 | finance.yahoo.comGraphite Bio, Inc. (GRPH)March 10, 2024 | marketwatch.comGraphite Bio to Pay Special Dividend Linked to Lenz Therapeutics MergerMarch 8, 2024 | au.investing.comGraphite Bio announces $1.03 per share special dividendMarch 28, 2024 | Behind the Markets (Ad)The Small Biotech with a BIG Cancer SolutionThere's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells.March 8, 2024 | msn.comGraphite Bio declares special $1.03 dividendMarch 8, 2024 | businesswire.comGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsFebruary 27, 2024 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHFebruary 2, 2024 | markets.businessinsider.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Graphite Bio, Inc. (GRPH)December 25, 2023 | seekingalpha.comGraphite Bio: Reverse Merger Leading Into Big Special Dividend And Q2 Phase 3 TrialNovember 27, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 40.00% to 7.14November 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 17, 2023 | businesswire.comGRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPHNovember 16, 2023 | benzinga.comShareholder Alert: Ademi LLP investigates whether Graphite Bio, Inc. has obtained a Fair Price in its transaction with LENZ TherapeuticsNovember 16, 2023 | bizjournals.comShattered dream of sickle cell disease cure to end in reverse merger for Peninsula biotechNovember 16, 2023 | finance.yahoo.comWhat Makes Graphite Bio, Inc. (GRPH) a New Buy StockNovember 15, 2023 | benzinga.comGRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to ShareholdersNovember 15, 2023 | markets.businessinsider.comGraphite Bio To Merge With LENZ Therapeutics; Stock Down In Pre-marketNovember 15, 2023 | finance.yahoo.comLENZ Therapeutics and Graphite Bio Announce Merger AgreementNovember 9, 2023 | morningstar.comGraphite Bio Inc GRPHNovember 1, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 25.00% to 5.10October 5, 2023 | msn.comGraphite Bio (GRPH) Price Target Increased by 11.11% to 4.08June 23, 2023 | seekingalpha.comGraphite Bio CFO resigns to pursue other opportunitiesSee More Headlines Receive GRPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graphite Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/20/2023Ex-Dividend for 3/21 Dividend3/15/2024Dividend Payable3/21/2024Today3/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:GRPH CUSIPN/A CIK1815776 Webwww.graphitebio.com Phone650-484-0886FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-124,650,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-33.12% Return on Assets-27.96% Debt Debt-to-Equity RatioN/A Current Ratio39.20 Quick Ratio39.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.15 per share Price / Book1.01Miscellaneous Outstanding Shares58,240,000Free Float35,874,000Market Cap$185.20 million OptionableNot Optionable Beta0.20 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. Matthew Porteus M.D. (Age 58)Ph.D., Academic Founder & Director Comp: $110kStephanie YaoVice President of Communications & Investor RelationsDr. Christine Garrett P.M.P. (Age 53)Ph.D., Chief Strategy Officer Key CompetitorsOmega TherapeuticsNASDAQ:OMGAGenfitNASDAQ:GNFTInnate PharmaNASDAQ:IPHA10X Capital Venture Acquisition Corp. IIINYSE:VCXBVaxartNASDAQ:VXRTView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 41,514 shares on 3/11/2024Ownership: 2.448%Goldman Sachs Group Inc.Sold 5,241 shares on 3/1/2024Ownership: 0.049%Virtu Financial LLCBought 34,893 shares on 2/26/2024Ownership: 0.060%Vanguard Group Inc.Bought 41,514 shares on 2/15/2024Ownership: 2.459%Citadel Advisors LLCBought 1,200 shares on 2/15/2024Ownership: 0.000%View All Institutional Transactions GRPH Stock Analysis - Frequently Asked Questions How have GRPH shares performed in 2024? Graphite Bio's stock was trading at $18.34 at the beginning of the year. Since then, GRPH stock has decreased by 82.7% and is now trading at $3.18. View the best growth stocks for 2024 here. How were Graphite Bio's earnings last quarter? Graphite Bio, Inc. (NASDAQ:GRPH) announced its quarterly earnings results on Monday, March, 20th. The company reported ($3.08) EPS for the quarter, topping analysts' consensus estimates of ($3.43) by $0.35. How often does Graphite Bio pay dividends? What is the dividend yield for Graphite Bio? Graphite Bio declared a dividend on Friday, March 15th. Stockholders of record on Monday, March 18th will be paid a dividend of $7.21 per share on Thursday, March 21st. This represents a yield of 28.93%. The ex-dividend date is Friday, March 15th. Read our dividend analysis for GRPH. When did Graphite Bio's stock split? Shares of Graphite Bio reverse split on Friday, March 22nd 2024. The 1-7 reverse split was announced on Friday, March 22nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 22nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. When did Graphite Bio IPO? Graphite Bio (GRPH) raised $224 million in an IPO on Friday, June 25th 2021. The company issued 14,000,000 shares at $15.00-$17.00 per share. Who are Graphite Bio's major shareholders? Graphite Bio's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.46%), Vanguard Group Inc. (2.45%), Nantahala Capital Management LLC (1.42%), BML Capital Management LLC (0.77%), BML Capital Management LLC (0.77%) and Sectoral Asset Management Inc. (0.76%). Insiders that own company stock include Biocapital LP Samsara and Phil Gutry. View institutional ownership trends. How do I buy shares of Graphite Bio? Shares of GRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GRPH) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graphite Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.